Treatment of Prostatic Carcinoma with Estracyt (Estramustine Phosphate)

Chemotherapy ◽  
1976 ◽  
pp. 475-479
Author(s):  
F. Balogh ◽  
Z. Szendroi ◽  
L. Kisbenedek ◽  
I. Könyves ◽  
I. Szendi
1992 ◽  
Vol 59 (1_suppl) ◽  
pp. 151-152
Author(s):  
T. Torelli ◽  
A.M. Bacchioni ◽  
P. Corrada ◽  
G.L. Leidi ◽  
G. Ordesi ◽  
...  

The authors report preliminary results of a study performed on six patients with by advanced, hormone-refractory prostate cancer. These patients were treated by estramustine phosphate (10 mg/kg) and methotrexate (60 mg/mq). Low toxicity allows the use of this therapy in outpatient regimens. Moreover, the high rate of partial responses (five patients) shows the remarkable efficacy of this therapy, even if follow-up and number of patients are not sufficient to reach definitive conclusions.


1981 ◽  
Vol 6 (2) ◽  
pp. 149-154 ◽  
Author(s):  
S. B. Andersson ◽  
P. O. Gunnarsson ◽  
T. Nilsson ◽  
G. Plym Forshell

1977 ◽  
Vol 118 (2) ◽  
pp. 288-291 ◽  
Author(s):  
Gerald P. Murphy ◽  
Robert P. Gibbons ◽  
Douglas E. Johnson ◽  
Stefan A. Loening ◽  
George R. Prout ◽  
...  

The Prostate ◽  
1982 ◽  
Vol 3 (2) ◽  
pp. 159-164 ◽  
Author(s):  
Andrea Veronesi ◽  
Filiberto Zattoni ◽  
Sergio Frustaci ◽  
Enzo Galligioni ◽  
Umberto Tirelli ◽  
...  

1981 ◽  
Vol 15 (1) ◽  
pp. 37-44 ◽  
Author(s):  
Å. Fritjofsson ◽  
B. J. Norlén ◽  
B. Högberg ◽  
M. Rajalakshmi ◽  
S. Z. Cekan ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document